In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy

Paul A. Foster, Simon P. Newman, Surindaer. K. Chander, Chloe Stengel, Roma Jhalli, Lawrence L. W. Woo, Barry V. L. Potter, Michael J. Reed, Atul Purohit

Research output: Contribution to journalArticlepeer-review

59 Citations (SciVal)
Original languageEnglish
Pages (from-to)5543-5549
JournalClinical Cancer Research
Issue number18
Publication statusPublished - 2006

Cite this